LRRK2 and Parkinson disease: In contrast, less-sensitive sporadic PD lines and healthy subject controls had heightened levels of mitochondrial complexes II (p < 0.001) and III (p < 0.001) following LRRK2-in-1 treatment, which was not observed in highly sensitive sporadic PD patient-derived fibroblast lines (Supp.